Company Number: 15054880

Analysis Date: 2025-07-20 12:49 UTC

Financial Health Assessment Report for BRADWELLCARE LIMITED

---

1. Financial Health Score: B

Explanation:
BRADWELLCARE LIMITED shows a solid foundational financial position given its first year of operation. The company maintains positive net assets and net current assets, indicating a healthy working capital position and no immediate liquidity distress. However, the very small scale of operations, minimal cash reserves, and director loans balancing current liabilities suggest cautious monitoring is warranted. The business is financially sound but at an early stage with limited financial depth—hence a grade of B reflecting good but developing health.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Cash at bank and in hand	132	Very low cash reserves; adequate for minimal current activity but limited buffer.
Current Liabilities	(1,500)	Negative current liabilities indicating net creditor position; includes director loans.
Net Current Assets	1,632	Positive working capital; company can meet short-term obligations comfortably.
Net Assets	1,632	Positive equity base; company has started building shareholder value.
Share Capital	1	Minimal share capital reflecting startup phase.
Profit and Loss Account	1,631	Retained earnings/profits accumulated in initial period, a positive sign.
Number of Employees	1	Micro-sized entity consistent with the company category and initial phase.

Interpretation:

• The company has a "healthy cash flow" symptom with positive net current assets, meaning it can cover its short-term debts without financial strain.
• "Symptoms of distress" are minimal but include very low cash and reliance on director loans to fund operations, suggesting some liquidity management risk if business does not scale soon.
• The absence of audit requirements and micro-entity accounting policies are typical for a small, new company but limit external scrutiny.

---

3. Diagnosis: Overall Financial Condition

BRADWELLCARE LIMITED is in the early stages of its business lifecycle, having incorporated in August 2023 and just completed its first financial year to August 2024. The company operates in the "Other human health activities" sector, likely providing niche health services.

The financial "vitals" show a stable and solvent position with positive net assets and net current assets. The company has kept overheads low, employing only one person (likely the director) and maintaining minimal fixed assets or liabilities. The director loan indicated in liabilities serves as an internal financing mechanism, common in startups but a point to monitor for financial independence.

No signs of financial distress or operational inefficiencies are evident yet, but the low cash balance and minimal capital base require prudent cash flow management and growth strategies to avoid liquidity stress as the business expands.

---

4. Recommendations

• Increase Cash Reserves: Aim to build a stronger cash buffer to cover at least 3 months of operating expenses, reducing reliance on director loans and improving liquidity resilience.
• Formalize Funding Strategy: Consider additional external funding or equity injection to diversify capital sources beyond director loans, enhancing financial stability.
• Monitor Working Capital: Keep tight control on receivables and payables cycles to maintain positive net current assets and avoid cash flow bottlenecks.
• Plan for Growth: Develop a clear business plan targeting increased turnover and profitability to move beyond the micro-entity stage, improving long-term viability.
• Maintain Compliance: Continue timely filings and adherence to small company accounting standards to avoid penalties and maintain good standing.
• Financial Forecasting: Implement regular financial forecasting and scenario planning to anticipate cash needs and investment requirements.
• Consider Audit if Growing: As the company grows, prepare for potential audit requirements which add credibility and investor confidence.

---